Dr Prabin Dahal
Contact information
Research groups
Prabin Dahal
DPhil PGCertTLHE FHEA
Head of Statistics & Sciences, Infectious Diseases Data Observatory
- Head of Statistics and Sciences, Infectious Diseases Data Observatory
- Module lead in Medical Statistics, MSc in Modelling for Global Health
- Teaching Fellow in Epidemiology & Statistics, MSc in International Health and Tropical Medicine
Research summary
I am a statistician based at Infectious Diseases Data Observatory (IDDO). I have a broad interest in epidemiology of infectious diseases (Malaria and Visceral Leishmaniasis in particular). My research has primarily focused on delineation of dose-response relationships for commonly used antimalarial drugs through individual participant data meta-analysis and assessment of safety of antileishmanial drugs.
Prior to my current role, I completed first and second degrees in Statistics from the University of Reading, spent a year at Safety Assessment and Pharmaceutical Development unit at GlaxoSmithKline supporting pre-clinical studies, and completed DPhil in Clinical Medicine on investigation of statistical issues in antimalarial clinical studies.
I was a Susan and George Brownlee Junior Research Fellow in Biomedical Sciences at Linacre College (2019-2021).
Key publications
-
Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review
Chhajed R. et al, (2024), The Lancet Regional Health - Southeast Asia, 22, 100317 - 100317
-
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis
Dahal P. et al, (2022), Malaria Journal, 21
-
Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis
(2019), Malaria Journal, 18
-
The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient data
(2015), The Lancet Infectious Diseases, 15, 692 - 702
-
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data
(2015), BMC Medicine, 13
Recent publications
-
Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review.
Takyi A. et al, (2025), Malaria journal, 24
-
Influence of context on engagement with COVID-19 testing: a scoping review of barriers and facilitators to testing for healthcare workers, care homes and schools in the UK
Andersen-Waine B. et al, (2025), BMJ Open, 15, e089062 - e089062
-
Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016
Yeabah TO. et al, (2025), F1000Research, 13, 672 - 672
-
A systematic review of the noma evidence landscape: current knowledge and gaps
Maguire BJ. et al, (2025)
-
A protocol for a systematic review and individual patient data meta-analysis investigating the relationship betweenPfkelch13mutations and response to artemisinin-based treatment for uncomplicated falciparum malaria
van Wyk S. et al, (2025)